Epigenetics in ENS development and Hirschsprung disease.
Hirschsprung disease (HSCR, OMIM 142623) is a neurocristopathy caused by a failure of the enteric nervous system (ENS) progenitors derived from neural crest cells (NCCs), to migrate, proliferate, differentiate or survive to and within the gastrointestinal tract, resulting in aganglionosis in the distal colon. The formation of the ENS is a complex process, which is regulated by a large range of molecules and signalling pathways involving both the NCCs and the intestinal environment. This tightly regulated process needs correct regulation of the expression of ENS specific genes. Alterations in the expression of these genes can have dramatic consequences. Several mechanisms that control the expression of genes have been described, such as DNA modification (epigenetic mechanisms), regulation of transcription (transcription factor, enhancers, repressors and silencers), post-transcriptional regulation (3'UTR and miRNAs) and regulation of translation. In this review, we focus on the epigenetic DNA modifications that have been described so far in the context of the ENS development. Moreover we describe the changes that are found in relation to the onset of HSCR.
Department of Genetics, Reproduction and Fetal Medicine, Institute of Biomedicine of Seville (IBIS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain; Centre for Biomedical Network Research on Rare Diseases (CIBERER), Seville, Spain.
A
A
Torroglosa
Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands.
M M
MM
Alves
Department of Genetics, Reproduction and Fetal Medicine, Institute of Biomedicine of Seville (IBIS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain; Centre for Biomedical Network Research on Rare Diseases (CIBERER), Seville, Spain.
R M
RM
Fernández
Department of Genetics, Reproduction and Fetal Medicine, Institute of Biomedicine of Seville (IBIS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain; Centre for Biomedical Network Research on Rare Diseases (CIBERER), Seville, Spain.
G
G
Antiñolo
Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands; Stem Cells and Regenerative Medicine, Birth Defects Research Centre UCL Institute of Child Health, London, UK.
R M
RM
Hofstra
Department of Genetics, Reproduction and Fetal Medicine, Institute of Biomedicine of Seville (IBIS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain; Centre for Biomedical Network Research on Rare Diseases (CIBERER), Seville, Spain. Electronic address: salud.borrego.sspa@juntadeandalucia.es.
S
S
Borrego
D019175:DNA Methylation / Q000235:genetics; D017615:Enteric Nervous System / Q000196:embryology*; D044127:Epigenesis, Genetic / Q000235:genetics; D041981:Gastrointestinal Tract / Q000196:embryology / Q000294:innervation*; D006627:Hirschsprung Disease / Q000196:embryology* / Q000235:genetics / Q000473:pathology*; D006657:Histones / Q000378:metabolism; D006801:Humans; D009432:Neural Crest / Q000166:cytology / Q000503:physiopathology*; D038081:Organogenesis / Q000235:genetics / Q000502:physiology*; D012323:RNA Processing, Post-Transcriptional / Q000235:genetics; D015398:Signal Transduction
D006657:Histones
Enteric nervous system; Epigenetics; Hirschsprung disease; Neural crest cells